Basic and Diluted Loss per Share (Details) - $ / shares |
9 Months Ended | |||||
|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2022 |
[1] | |||
| Basic and Diluted Loss per Share [Line Items] | ||||||
| Convertible shares outstanding | 90,377 | 94,018 | ||||
| Exercise price (in Dollars per share) | $ 3.94 | $ 4.53 | ||||
| Purchase of common stock shares | 72,945 | |||||
| Average grant date fair value per share (in Dollars per share) | $ 11.1 | $ 16.2 | ||||
| Common Stock [Member] | ||||||
| Basic and Diluted Loss per Share [Line Items] | ||||||
| Convertible shares outstanding | 1,047,589 | 7,736 | ||||
| ||||||
| X | ||||||||||
- Definition Basic and Diluted Loss per Share [Line Items]. No definition available.
|
| X | ||||||||||
- Definition The warrants are convertible into common stock. No definition available.
|
| X | ||||||||||
- Definition Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|